Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00364702|
Recruitment Status : Completed
First Posted : August 16, 2006
Last Update Posted : August 17, 2011
|Condition or disease||Intervention/treatment||Phase|
|ADHD||Drug: methylphenidate||Phase 2|
Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADHD will use the program with and without methylphenidate(1 mg/kg). Their results will be compared to a control group.
Parental consent will be obtained.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||None (Open Label)|
|Official Title:||Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder|
|Study Start Date :||August 2006|
|Actual Primary Completion Date :||July 2007|
|Actual Study Completion Date :||July 2007|
- Virtual Reality program test results
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00364702
|Shaari Zedek Pediatric Neurology Unit|
|Jerusalem, Israel, 91031|
|Study Chair:||V. Gross, Prof/ md||Shaari Zedek Pediatric Neurology Unit|